Poneh Heine, MD
Allergy & Immunology · Lawrenceville, GANPI 1881822492
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,804 of the $13,566 with a category attached, or 87.0%. 36 manufacturers reported payments, led by Sanofi at 30.7% of the total. 2025 is the largest year on record at $5,507, 6.2 times the $889 reported in 2019.
Across 502 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- Amgen$653
- CSL Behring$606
- plus $5K from 30 others
What the payments were for
- Consulting fees$1,46311%
- Food & beverage$11,80487%
- Education$3002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 83 | $4,169 |
| AstraZeneca | 60 | $1,220 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,109 |
| GSK | 72 | $1,077 |
| Amgen(2 entities) | 24 | $653 |
| CSL Behring | 18 | $606 |
| Pfizer | 25 | $458 |
| Optinose US, Inc. | 24 | $451 |
| Octapharma USA, Inc. | 7 | $351 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $339 |
| Kaleo, Inc. | 18 | $332 |
| Novartis | 13 | $282 |
| Sanofi-aventis U.S. LLC | 3 | $242 |
| Teva Pharmaceuticals USA, Inc. | 13 | $225 |
| Grifols USA, LLC | 12 | $214 |
| Alk-abello, Inc | 9 | $203 |
| Boehringer Ingelheim | 9 | $187 |
| Pharming Healthcare, Inc. | 6 | $167 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $162 |
| Biocryst US Sales Co., LLC | 7 | $154 |
| Shire North American Group Inc | 2 | $150 |
| Covis Pharma GmbH | 6 | $143 |
| Galderma Laboratories, L.p. | 4 | $131 |
| Blueprint Medicines Corporation | 4 | $118 |
| Eyevance Pharmaceuticals LLC | 3 | $57 |
| Organon | 4 | $55 |
| Merck | 3 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
| Cycle Pharmaceuticals Inc | 2 | $39 |
| Mylan Specialty L.p. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Genentech USA, Inc. | 1 | $26 |
| Biocryst Pharmaceuticals, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,566 in reported general payments places this provider in the 80th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $23,294 |
| Advair HfaFluticasone Propion/Salmeterol | 18 | $10,782 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $8,316 |
| Arnuity ElliptaFluticasone Furoate | 21 | $6,367 |
| Epinephrine | 21 | $3,320 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 15 | $1,486 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,311 |
| Montelukast Sodium | 118 | $667 |
| Fluticasone Propionate | 24 | $395 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $352 |
| Ipratropium Bromide | 12 | $237 |
| Prednisone | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,077 | $37,97664 claims |
| Hikma Pharmaceuticals USAEpinephrine | $36 | $3,32021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 107 allergy & immunology providers in Georgia.
Other allergy & immunology in Lawrenceville
- Byol ShinLawrenceville$12K
- Syeda HamadaniLawrenceville$6K
- Michael BlaissRoswell$1.1M
- Deborah BirxAtlanta$470K
- Tracy BridgesAlbany$364K
- Jack EadesMacon$237K
- Stanley FinemanMarietta$186K
- Robert CartwrightColumbus$169K
- Robert ChrzanowskiColumbus$115K
- Belinda GrahamSmyrna$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.